MEDICINOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
MEDICINOVA, INC. (MNOV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.23 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 133.50K shares, a 122.50% increase year-over-year.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.10M shares, a 16.70% decline year-over-year.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 100.00K shares.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.48M shares, a 34.59% increase from fiscal 2024.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.10M shares, a 39.47% increase from fiscal 2023.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 788.68K shares, a 33.29% increase from fiscal 2022.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 591.70K shares, a 55.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 133.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 1.23M shares 10-Q · filed 2026-08-13 | 1.33M shares derived: sum of 3 quarters · filed 2026-08-13 | 1.33M shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 1.10M shares 10-Q · filed 2026-05-14 | 1.20M shares derived: sum of 2 quarters · filed 2026-05-14 | 1.20M shares derived: sum of 3 quarters · filed 2026-05-14 | 1.26M shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 100.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 100.00K shares derived: sum of 2 quarters · filed 2026-03-10 | 160.00K shares derived: sum of 3 quarters · filed 2026-03-10 | 1.48M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 60.00K shares derived: sum of 2 quarters · filed 2025-11-12 | 1.38M shares 10-Q · filed 2025-11-12 | 1.38M shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-06-30 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 1.38M shares 10-Q · filed 2025-08-14 | 1.38M shares derived: sum of 3 quarters · filed 2026-03-10 | 1.38M shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-03-31 | 1.32M shares 10-Q · filed 2025-05-13 | 1.32M shares derived: sum of 2 quarters · filed 2026-03-10 | 1.32M shares derived: sum of 3 quarters · filed 2026-03-10 | 1.40M shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-10 | 84.00K shares derived: sum of 3 quarters · filed 2026-03-10 | 1.10M shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 84.00K shares derived: sum of 2 quarters · filed 2024-11-13 | 1.10M shares 10-Q · filed 2024-11-13 | 1.10M shares derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-06-30 | 84.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.10M shares 10-Q · filed 2024-08-08 | 1.10M shares derived: sum of 3 quarters · filed 2025-02-19 | 1.12M shares derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-03-31 | 1.02M shares 10-Q · filed 2024-05-09 | 1.02M shares derived: sum of 2 quarters · filed 2025-02-19 | 1.03M shares derived: sum of 3 quarters · filed 2025-02-19 | 1.07M shares derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | 18.33K shares derived: sum of 2 quarters · filed 2025-02-19 | 58.33K shares derived: sum of 3 quarters · filed 2025-02-19 | 788.68K shares 10-K · filed 2025-02-19 |
| 2023-09-30 | 18.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 58.33K shares derived: sum of 2 quarters · filed 2023-11-09 | 788.68K shares 10-Q · filed 2023-11-09 | 788.68K shares derived: sum of 4 quarters · filed 2024-02-15 |
| 2023-06-30 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 770.35K shares 10-Q · filed 2023-08-09 | 770.35K shares derived: sum of 3 quarters · filed 2024-02-15 | 770.35K shares derived: sum of 4 quarters · filed 2024-02-15 |
| 2023-03-31 | 730.35K shares 10-Q · filed 2023-05-11 | 730.35K shares derived: sum of 2 quarters · filed 2024-02-15 | 730.35K shares derived: sum of 3 quarters · filed 2024-02-15 | 788.35K shares derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-15 | 58.00K shares derived: sum of 3 quarters · filed 2024-02-15 | 591.70K shares 10-K · filed 2024-02-15 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 58.00K shares derived: sum of 2 quarters · filed 2022-11-10 | 591.70K shares 10-Q · filed 2022-11-10 | 591.70K shares derived: sum of 4 quarters · filed 2023-03-28 |
| 2022-06-30 | 58.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 591.70K shares 10-Q · filed 2022-08-11 | 591.70K shares derived: sum of 3 quarters · filed 2023-03-28 | 591.70K shares derived: sum of 4 quarters · filed 2023-03-28 |
| 2022-03-31 | 533.70K shares 10-Q · filed 2022-05-12 | 533.70K shares derived: sum of 2 quarters · filed 2023-03-28 | 533.70K shares derived: sum of 3 quarters · filed 2023-03-28 | 627.70K shares derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-28 | 94.00K shares derived: sum of 3 quarters · filed 2023-03-28 | 1.31M shares 10-K/A · filed 2023-03-28 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 94.00K shares derived: sum of 2 quarters · filed 2021-11-12 | 1.31M shares 10-Q · filed 2021-11-12 | 1.33M shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-06-30 | 94.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 1.31M shares 10-Q · filed 2021-08-12 | 1.33M shares derived: sum of 3 quarters · filed 2022-02-16 | 1.37M shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-03-31 | 1.22M shares 10-Q · filed 2021-05-13 | 1.24M shares derived: sum of 2 quarters · filed 2022-02-16 | 1.27M shares derived: sum of 3 quarters · filed 2022-02-16 | 1.39M shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | 51.00K shares derived: sum of 2 quarters · filed 2022-02-16 | 171.00K shares derived: sum of 3 quarters · filed 2022-02-16 | 1.38M shares 10-K · filed 2022-02-16 |
| 2020-09-30 | 36.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | 156.00K shares derived: sum of 2 quarters · filed 2020-10-26 | 1.37M shares 10-Q · filed 2020-10-26 | 1.37M shares derived: sum of 4 quarters · filed 2021-02-19 |
| 2020-06-30 | 120.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 1.33M shares 10-Q · filed 2020-07-28 | 1.33M shares derived: sum of 3 quarters · filed 2021-02-19 | 1.33M shares derived: sum of 4 quarters · filed 2021-02-19 |
| 2020-03-31 | 1.21M shares 10-Q · filed 2020-04-23 | 1.21M shares derived: sum of 2 quarters · filed 2021-02-19 | 1.21M shares derived: sum of 3 quarters · filed 2021-02-19 | 1.27M shares derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | 0.00 shares derived: sum of 2 quarters · filed 2021-02-19 | 60.00K shares derived: sum of 3 quarters · filed 2021-02-19 | 1.34M shares 10-K · filed 2021-02-19 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | 60.00K shares derived: sum of 2 quarters · filed 2019-10-24 | 1.34M shares 10-Q · filed 2019-10-24 | 1.34M shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2019-06-30 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | 1.34M shares 10-Q · filed 2019-07-25 | 1.34M shares derived: sum of 3 quarters · filed 2020-02-13 | 1.34M shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2019-03-31 | 1.28M shares 10-Q · filed 2019-04-25 | 1.28M shares derived: sum of 2 quarters · filed 2020-02-13 | 1.28M shares derived: sum of 3 quarters · filed 2020-02-13 | 1.34M shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 0.00 shares derived: sum of 2 quarters · filed 2020-02-13 | 60.00K shares derived: sum of 3 quarters · filed 2020-02-13 | 1.22M shares 10-K · filed 2020-02-13 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | 60.00K shares derived: sum of 2 quarters · filed 2018-10-25 | 1.22M shares 10-Q · filed 2018-10-25 | 1.26M shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2018-06-30 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | 1.22M shares 10-Q · filed 2018-07-23 | 1.26M shares derived: sum of 3 quarters · filed 2019-02-13 | 1.26M shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2018-03-31 | 1.16M shares 10-Q · filed 2018-04-25 | 1.20M shares derived: sum of 2 quarters · filed 2019-02-13 | 1.20M shares derived: sum of 3 quarters · filed 2019-02-13 | 1.24M shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-12-31 | 35.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | 35.00K shares derived: sum of 2 quarters · filed 2019-02-13 | 75.00K shares derived: sum of 3 quarters · filed 2019-02-13 | 1.20M shares 10-K · filed 2019-02-13 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | 40.00K shares derived: sum of 2 quarters · filed 2017-10-23 | 1.16M shares 10-Q · filed 2017-10-23 | 1.16M shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | 1.16M shares 10-Q · filed 2017-07-26 | 1.16M shares derived: sum of 3 quarters · filed 2019-02-13 | 1.16M shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | 1.12M shares 10-Q · filed 2017-04-26 | 1.12M shares derived: sum of 2 quarters · filed 2019-02-13 | 1.12M shares derived: sum of 3 quarters · filed 2019-02-13 | 1.16M shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | 0.00 shares derived: sum of 2 quarters · filed 2019-02-13 | 40.00K shares derived: sum of 3 quarters · filed 2019-02-13 | 1.16M shares 10-K · filed 2019-02-13 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-25 | 40.00K shares derived: sum of 2 quarters · filed 2016-10-25 | 1.16M shares 10-Q · filed 2016-10-25 | 1.16M shares derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26 | 1.16M shares 10-Q · filed 2016-07-26 | 1.16M shares derived: sum of 3 quarters · filed 2018-02-13 | 1.20M shares derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | 1.12M shares 10-Q · filed 2016-04-27 | 1.12M shares derived: sum of 2 quarters · filed 2018-02-13 | 1.16M shares derived: sum of 3 quarters · filed 2018-02-13 | 1.16M shares derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | 40.00K shares derived: sum of 2 quarters · filed 2018-02-13 | 40.00K shares derived: sum of 3 quarters · filed 2018-02-13 | 689.00K shares 10-K · filed 2018-02-13 |
| 2015-09-30 | 40.00K shares 10-Q · filed 2015-10-29 | 40.00K shares derived: sum of 2 quarters · filed 2015-10-29 | 689.00K shares 10-Q · filed 2015-10-29 | 884.00K shares derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | 649.00K shares 10-Q · filed 2015-07-30 | 844.00K shares derived: sum of 3 quarters · filed 2017-02-14 | 854.00K shares derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | 649.00K shares 10-Q · filed 2015-05-11 | 844.00K shares derived: sum of 2 quarters · filed 2017-02-14 | 854.00K shares derived: sum of 3 quarters · filed 2017-02-14 | 949.00K shares derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | 195.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | 205.00K shares derived: sum of 2 quarters · filed 2017-02-14 | 300.00K shares derived: sum of 3 quarters · filed 2017-02-14 | 300.00K shares 10-K · filed 2017-02-14 |
| 2014-09-30 | 10.00K shares 10-Q · filed 2014-11-13 | 105.00K shares derived: sum of 2 quarters · filed 2014-11-13 | 105.00K shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 95.00K shares 10-Q · filed 2014-08-13 | 95.00K shares 10-Q · filed 2014-08-13 | ||
| 2013-12-31 | 740.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | 740.50K shares derived: sum of 2 quarters · filed 2015-03-12 | 1.61M shares derived: sum of 3 quarters · filed 2015-03-12 | 1.61M shares 10-K · filed 2015-03-12 |
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-07 | 867.50K shares derived: sum of 2 quarters · filed 2013-11-07 | 867.50K shares 10-Q · filed 2013-11-07 | |
| 2013-06-30 | 867.50K shares 10-Q · filed 2013-08-08 | 867.50K shares 10-Q · filed 2013-08-08 | ||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | 735.00K shares derived: sum of 2 quarters · filed 2014-03-27 | 750.00K shares derived: sum of 3 quarters · filed 2014-03-27 | 750.00K shares 10-K · filed 2014-03-27 |
| 2012-09-30 | 735.00K shares 10-Q · filed 2013-11-07 | 750.00K shares derived: sum of 2 quarters · filed 2013-11-07 | 750.00K shares 10-Q · filed 2013-11-07 | |
| 2012-06-30 | 15.00K shares 10-Q · filed 2013-08-08 | 15.00K shares 10-Q · filed 2013-08-08 | ||
| 2011-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | 1.43M shares derived: sum of 2 quarters · filed 2013-03-28 | 1.43M shares derived: sum of 3 quarters · filed 2013-03-28 | 1.43M shares 10-K · filed 2013-03-28 |
| 2011-09-30 | 1.41M shares 10-Q · filed 2012-11-08 | 1.42M shares derived: sum of 2 quarters · filed 2012-11-08 | 1.42M shares 10-Q · filed 2012-11-08 | |
| 2011-06-30 | 4.00K shares 10-Q · filed 2012-08-09 | 4.00K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |